SCHEMBL7401906

SCHEMBL7401906

NC(=O)CNc1nc(C(OC2CCCCO2)c2ccccc2)ns1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.36
PTGER4 P35408 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HPGD P15428 3/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
PKM P14618 1/20 0.32
CYP2C19 P33261 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
OPRM1 P35372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7445316 0.90 SLC6A3 (0.40) SLC6A3PTGER4CA12CA1CA2
SCHEMBL4781667 0.78 PTGER4 (0.37) SLC6A3PTGER4CCNA2CDK2CCNA1
SCHEMBL7638191 0.72 KCNK3 (0.40) SLC6A3PTGER4CYP3A4KMT2AALDH1A1
SCHEMBL29167883 0.71 SLC6A3 (0.44) SLC6A3PTGER4HPGDCYP3A4CYP2D6
SCHEMBL8486905 0.69 PTGER4 (0.35) SLC6A3PTGER4CYP3A4CYP2D6MEN1
SCHEMBL7446726 0.68 PTGER4 (0.46) SLC6A3PTGER4CCNA2CDK2CCNA1
SCHEMBL8168868 0.68 KDM4E (0.40) SLC6A3TDP1KDM4EALDH1A1HSD17B10
SCHEMBL10391386 0.68 SLC6A3 (0.49) SLC6A3PTGER4TDP1HPGDCYP3A4
SCHEMBL7400415 0.68 PTGER4 (0.33) SLC6A3PTGER4CYP3A4CYP2D6CYP2C19
SCHEMBL8172478 0.66 KDM4E (0.40) SLC6A3PTGER4TDP1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed
WO-2001090095-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2001-11-29 WO disclosed
US-6162791-A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes APOTEX INC. (CA) 2000-12-19 US disclosed
EP-1058690-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2000-12-13 EP disclosed
WO-1999045027-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 1999-09-10 WO disclosed